Lecture 5: Hormone Signaling Pathways Flashcards

1
Q

Why is only a small amount of hormone necessary to generate a signal?

A

The effect of hormone binding to its receptor is magnified via amplification.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Once the ligand binds to its receptor - the receptor complex can do what to cellular pathways?

A
  • Activate or inhibit cellular pathway (s) that elicit a particular cellular response (enzyme activity, gene expression)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Differentiate endocrine, paracrine, autocrine, and juxtacrine signaling; give an example of a molecule that participates in each one?

A

Endocrine: signaling molecule released by a cell distant to target and transported via bloodstream to target. i.e., epinephrine

Paracrine: signaling molecule released by one cell type and diffused to a neighboring target cells of different cell type i.e. testosterone

Autocrine: signaling molecule acts on the same cell type as the secreting cells themselves i.e. IL-1

Juxtacrine: signaling molecule stays attached to the secreting cell and binds to a receptor on an adjacent target cell i.e. heparin-binding epidermal growth factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Can a signaling molecule be used in more than one type of signaling?

A

Yes, some molecules may participate in more than one type of signaling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the receptor involved in hydrophilic hormone signaling; what does the signaling molecule-receptor complex initiate?

A
  • GPCRs
  • RTKs
  • Initiates production of second messenger molecules inside cell
  • Both found on the surface of target cells, since the signaling molecule won’t be able to diffuse throught the membrane
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the receptor types for lipophillic hormone signaling (differentiate between the two); binding to the receptor does what?

A
  • Cytoplasmic receptors: exist as inactive complex. Upon binding, the hormone-receptor complex translocates to nucleus where it binds to a specific DNA sequence called the hormone response element (HRE)

- Nuclear receptors: already present in nucleus bound to DNA. The hormone allows for interaction w/ additional proteins and activates the complex

  • Signaling molecule-receptor complex acts as a transcription factor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Differentiate between hydrophilic and lipophilic medications?

A

Hydrophilic: have short 1/2-lives (seconds to mins.). Given a the time of need, like epinephrine.

Lipophilic: have long 1/2-lives (hours to days). Need to take daily, like oral contrapceptives.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are lipophilic signaling molecules?

A
  • Steroid hormones: progesterone, estradiol, testosterone, cortisol
  • Thyroid hormone: thyroxine (T4)
  • Retinoids: retinol, retinoic acid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some hydrophilic signaling molecules?

A
  • AA derivatives: histamine, serotonin, melatonin, dopamine, NE, epi
  • Acetylcholine
  • Polypeptides: insulin, glucagon, cytokines, TSH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Explain the general mechanism for GPCR signaling

A
  • Trimeric G-proteins contain three subunits (α, β, γ)
  • Inactive G protein has GDP bound to α subunit, and to become active G protein must exchange GDP for GTP using GEF, and α-subunit separates from beta and gamma subunits
  • To return to inactive state, intrinsic GTPase activity of G protein hydrolyzes bound GTP into GDP + Pi w/ help from GTPase-activating protein (GAP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What occurs when a signaling molecule binds to a GPCR using Gs pathway?

A
  • Stimulates adenyly cyclase, which increases cAMP that can activate PKA.
  • PKA will phosphorylate target proteins to alter their activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What occurs when a signaling molecule binds to a GPCR using Gt pathway?

A
  • Light hits a GPCR leading to the stimulation of cGMP phosphodiesterase, which converts cGMP –> 5-GMP, halting any action being promoted by cGMP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What occurs when a signaling molecule binds to a GPCR using Gi pathway?

A
  • Signaling molecule binds causing the inhibition of adenylyl cyclase so NO cAMP is produced, and PKA is NOT activated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What occurs when a signaling molecule binds to a GPCR using Gq pathway?

A
  • Activates PLC, which produces the second messengers DAG and IP3
  • IP3 leads to increased Ca2+
  • DAG leads to the activation of PKC, which phosphorylates target proteins to alter their activities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Epinephrine, histamine, and NE bind to what type of receptors, activating which GPCR pathways?

A
  • Epinephrine binds β-adrenergic receptor activating Gs
  • Histamine binds H2-receptor activating Gs
  • Epinephrine/NE bind α-adrenergic receptor activating Gi
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Dopamine, ACh, and light bind to what receptors utilizing which GPCR pathway?

A
  • Dopamine binds D2-receptor utilizing the Gi pathway
  • ACh binds the M3-receptor utilizing the Gq pathway
  • Light activates rhodopsin receptor utilizing Gt pathway
17
Q

What is the structure of insulin?

A
  • Two polypeptide chains referred to as the A chain (21 AA’s) and B chain (30 AA’s)
  • Linked together by two disulfide bridges (S-S)
18
Q

What is the secondary and tertiary structure of insulin; active vs inactive structure?

A
  • 3-fold symmetry w/ Zinc in the center connected via histidines
  • Inactive stored in body as a Hexamer

- Active form is a monomer

19
Q

Describe the basic process underlying insulin synthesis and secretion

A
  • Glucose upregulates preproinsulin mRNA
  • Translated into preproinsulin protein in the ribosome
  • Cleaved by a protease to form proinsulin
  • Folded and transported to Golgi to be packaged into granules
  • C-chain cleaved to form A-chain + B-chain insulin structure
20
Q

What are the 2 phases of insulin release after glucose stimulation?

A

1) First (rapid but transient) release comes from a limited pool of granules referred to as the readily releasabel pool (RRP)
2) Second (sustained) phase comes from a larger pool referred to as the reserve pool.

21
Q

How does glucose cause the release of insulin granules from the pancreatic β-cell?

A
  • Glucose enters the cell via GLUT 2 and will undergo glycolysis –> PDH –> TCA producing ATP/ADP
  • ATP/ADP caused the closing of ATP-sensitive K+ channels, which lead to the opening of Ca2+ channels
  • Opening of the Ca2+ channels stimulate the release of insulin granules into the blood
22
Q

Describe the mechanism upon insulin binding the RTK that involves the RAS pathway.

A
  • Insulin binds RTK, receptor becomes dimerized and autophosphorylates tyrosine residues.
  • IRS-1 is recruited and becomes phosphorylated, attracting the scaffolding protein called GRB-2, which activates the RAS pathway
  • RAS pathway phosphorylates nuclear proteins causing an increase in the transcription of Glucokinase and increased glucose uptake
23
Q

Describe the mechanism upon insulin binding the RTK that involves the RAS-independent pathway.

A
  • Insulin binds RTK, receptors dimerizes, autophosphorylates tyrosine residues.
  • IRS-1 is recruited and phosphorylated, then recruits PI 3-kinase, which activates PKB via phosphorylation
  • PKB phosphorylates many nuclear proteins and trigger the translocation of GLUT4 to plasma membrane; activation of glycogen synthase
  • Leads to increased glucose uptake and glycogen synthesis
24
Q

How can insulin be measured in a Quantifiable manner?

A

Measured as amount of glucose cleared from the blood in response to a fixed dose of insulin

25
Q

What are some of the defects that can lead to insulin resistance?

A
  • Defect in insulin signaling
  • Defect in the insulin receptor due to mutations
  • Defects in the insulin binding domain extracellularly and/or intracellularly (cause severe insulin resistance)
  • Defects in IRS1 and IRS2
  • Phosphorylation of serine instead of tyrosine disrupts downstream signal
26
Q

What molecules can lead to the phosphorylation of Ser/Thr and contribute to insulin resistance; what is the bodies response?

A
  • Cytokines, FFA’s DAG, ceramide, and inflammatory molecules
  • Lead to degradation of the protein because body recognized it as foreign
27
Q

How do epinephrine and cortisol affect glucose metabolism?

A

Epinephrine: stmulates glycogen breakdown by promoting glucagon secretion

Cortisol: stimulates gluconeogenesis upon the depletio of glycogen stores, by inducing transcription of enzymes involved in the pathway

28
Q

What are the 2 types of Nuclear Receptors; examples of the hormones that bind?

A

Classic NR: ligands are lipophilic hormones. Glucocorticoids, mineralcorticoids, estrogen, progesterone, and androgens

Orphan Receptors: other receptos discovered by DNA sequencing (ligands unknown)

29
Q

What does the term “adopted” orphan receptor mean; examples of these ligands?

A
  • When a ligand has been discovered for an orphan receptor it becomes known as “adopted”
  • Retinoids, thyroid hormones, Vit D, xenobiotics, androstane, etc..
30
Q

Where are Nuclear Receptors located and why are they important?

A
  • Located in nucleus or in cytosol
  • Important drug targets
31
Q

What are the 3 major domains of nuclear receptors and function of each?

A

1) Activation Function 1 Domain (AF1) - modify the conformation of the entire receptor
2) DNA binding domain (DBD) - binds to regulatory sequences on DNA called hormone response element (HRE)
3) Ligand binding domain (LBD) - binds to various molecules (agonist or antagonist) which regulates ligand-dependent activation of receptor

32
Q

What is the primary (early) response to steroid hormone vs. secondary (delayed) response?

A
  • Ligand binds, conformational change occurs, and will either come to nucleus to interact w/ DNA (cytoplasmic receptor) or form active complex to the HRE (nuclear recptor)
  • Activating gene expression will induce synthesis of primary-response proteins, which can go on to block primary-response genes and turn on secondary-response genes, mediating the secondary (delayed) response.
33
Q

What are the 2 types of estrogen receptors and both acts as estrogen-dependent what; which cells express them?

A
  • ERα and ERβ
  • Both are estrogen-dependent transcription factors
  • Many cells express BOTH ERα and ERβ
34
Q

Where is ERα expressed most abundantly?

A
  • Female reproductive tract (uterus, vagina, and ovaries)
  • Mammary gland, hypothalamus, endothelial cells, and vascular smooth muscle
35
Q

Where is ERβ expressed most abundantly?

A
  • Prostate, ovaries, w/ lower expression in lung, brain, bone, and vasculature
36
Q

Explain the binding of estrogen to the estrogen receptors (ERα,ERβ)

A
  • Estrogen receptor located in the nucleus, upon binding of estrogen undergoes a conformaional change, which involve the binding of many nuclear proteins
  • Results in activation of HAT, an enzyme that modifies chromatin structure.
  • Recruits proteins that comprise the general transcription apparatus, leading to enhances transcription to form mRNA
37
Q

How does Tamoxifen affect the mechanism of estrogen signaling and what is it commonly used for?

A
  • Breast cancer drug similar in structure to that of estrogen.
  • Tamoxifen, an antagonist, is metabolized by CYP450 in liver to 4-hydroxy-tamoxifen, which has slightly different structure than estrogen so binds receptor in different place
  • Different downstream proteins are activated and bind the complex and the end result is the activation of Histone Deacetylase (HDAC), which keeps DNA in chromatin form and inhibits transcription
  • Effective cancer drug because it stops the proliferation of cancer cells
38
Q

What are Non-genomic estrogen signaling pathways?

A
  • Some ER’s located in the plasma membrane
  • Belong to the GPCR and RTK type of receptors
  • Effects mediated through metabolic changes as well as changes in gene expression